Ascendis Pharma AS (ASND)
129.96
+5.68
(+4.57%)
USD |
NASDAQ |
Nov 15, 11:20
Ascendis Pharma Net Income (TTM): -530.29M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -530.29M |
| March 31, 2024 | -544.93M |
| December 31, 2023 | -521.73M |
| September 30, 2023 | -640.26M |
| June 30, 2023 | -633.83M |
| March 31, 2023 | -588.03M |
| December 31, 2022 | -609.73M |
| September 30, 2022 | -518.95M |
| June 30, 2022 | -443.48M |
| March 31, 2022 | -518.81M |
| December 31, 2021 | -453.65M |
| September 30, 2021 | -498.03M |
| June 30, 2021 | -545.66M |
| March 31, 2021 | -488.27M |
| December 31, 2020 | -482.48M |
| September 30, 2020 | -405.77M |
| June 30, 2020 | -291.33M |
| March 31, 2020 | -252.96M |
| December 31, 2019 | -244.01M |
| September 30, 2019 | -191.51M |
| Date | Value |
|---|---|
| June 30, 2019 | -203.08M |
| March 31, 2019 | -164.11M |
| December 31, 2018 | -154.01M |
| September 30, 2018 | -157.76M |
| June 30, 2018 | -158.10M |
| March 31, 2018 | -164.68M |
| December 31, 2017 | -140.64M |
| September 30, 2017 | -118.14M |
| June 30, 2017 | -98.68M |
| March 31, 2017 | -79.91M |
| December 31, 2016 | -75.76M |
| September 30, 2016 | -71.14M |
| June 30, 2016 | -58.89M |
| March 31, 2016 | -60.50M |
| December 31, 2015 | -36.26M |
| September 30, 2015 | -29.43M |
| June 30, 2015 | -23.93M |
| March 31, 2015 | -10.24M |
| December 31, 2014 | -12.54M |
| September 30, 2014 | -3.176M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-640.26M
Minimum
Sep 2023
-244.01M
Maximum
Dec 2019
-484.85M
Average
-518.81M
Median
Mar 2022
Net Income (TTM) Benchmarks
| Novo Nordisk AS | 13.79B |
| Evaxion Biotech AS | -11.46M |
| Biodexa Pharmaceuticals PLC | -8.534M |
| NuCana PLC | -35.48M |
| Genfit SA | -- |